Ardigo and Caruso of CBRE represent tenant in 149,000 s/f lease

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, has signed a 10-year, 149,000 s/f lease at The Landmark at Eastview, located at 765 Old Saw Mill River Rd. where it has been headquartered for over a decade. Patricia Ardigo, first VP and director of CB Richard Ellis' life sciences group, and Robert Caruso, senior managing director of its Westchester/Fairfield operation, represented Progenics. Bill Kane, director of leasing & acquisitions for the property's management, BioMed Realty Trust, Inc., represented the owner, BMR-Landmark at Eastview, LLC. "The Landmark at Eastview is known for its natural setting, distinctive architecture and sophisticated research and development facilities," said Ardigo. "Progenics opted to sign a new lease as the facilities have proven to be the ideal environment to support the firm's research and growth." The Landmark at Eastview is a 1,111,000 s/f multi-tenanted science park comprised of research, manufacturing and office space in central of Westchester County. The life science complex recently added a 360,000 s/f, three-building addition to its original/existing 751,000 rentable s/f. The property's prime location provides easily access to 1-287, 1-87, the Saw Mill River Pwy., Sprain Brook Pwy., Bronx River Pwy., and Hutchinson River Pwy., and is in close proximity to Metro North's White Plains and Tarrytown train stations.